Results 271 to 280 of about 1,279,892 (312)

Excess Productivity Costs of Systemic Lupus Erythematosus, Systemic Sclerosis, and Sjögren's Syndrome: A General Population–Based Study

Arthritis Care & Research, 2018
ObjectiveTo determine excess productivity losses and costs of systemic lupus erythematosus (SLE), systemic sclerosis (SSc), and Sjögren's syndrome (SS) at the population level.MethodsAdministrative databases from the province of British Columbia, Canada, were used to establish population‐based cohorts of SLE, SSc, and SS, and matched comparison cohorts
Natalie McCormick, Carlo A. Marra, Mohsen Sadatsafavi, Jacek A. Kopec, J. Antonio Aviña‐Zubieta   +4 more
openaire   +2 more sources

[Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].

L'Encephale, 2002
We present one case of Sjögren's syndrome (SS) secondary to systemic lupus erythematosus (SLE) with predominant psychiatric manifestations, treated with success by cyclophosphamide. From this case, we review the psychiatric aspects of these two autoimmune diseases as described in the literature and we present the etiopathogenic hypothesis and treatment
J F, Ampélas, M J, Wattiaux, A P, Van Amerongen   +2 more
openaire   +1 more source

Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis

Scandinavian Journal of Rheumatology, 2009
T-cell DNA hypomethylation is thought to contribute to the development of systemic erythematosus lupus (SLE). However, it is unknown whether impaired T-cell DNA methylation occurs in other connective tissue diseases, such as systemic sclerosis (SSc) and dermatomyositis (DM).We quantified global methylation in CD4+ T cells from 12 healthy donors and ...
W, Lei, Y, Luo, W, Lei, Y, Luo, K, Yan, S, Zhao, Y, Li, X, Qiu, Y, Zhou, H, Long, M, Zhao, Y, Liang, Y, Su, Q, Lu   +13 more
openaire   +2 more sources

OxLDL/β2GPI Complexes and Autoantibodies in Patients with Systemic Lupus Erythematosus, Systemic Sclerosis, and Antiphospholipid Syndrome: Pathogenic Implications for Vascular Involvement

Annals of the New York Academy of Sciences, 2005
Oxidized low-density lipoprotein (oxLDL) interacts with beta2GPI, forming oxLDL/beta2GPI complexes. Autoimmune vascular inflammation (and oxidative stress) may promote the formation of these complexes. The coexistence of oxLDL/beta2GPI complexes with autoantibodies to these complexes suggests an active pro-atherogenic role in vascular thrombosis and ...
Luis R, Lopez, Daniel F, Simpson, Beth L, Hurley, Eiji, Matsuura   +3 more
openaire   +2 more sources

Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or rheumatoid arthritis

Clinical Rheumatology, 2014
Because overlap syndromes (OSs) are rarely described, we analyzed retrospectively their frequencies and correlations in Brazilian series of 31 patients with dermatomyositis (DM)/polymyositis (PM) associated with systemic lupus erythematosus (SLE), systemic sclerosis (SSc), or rheumatoid arthritis (RA) attended at a referral single center.
Lisbeth Aranbicia, Aguila, Michelle Remião Ugolini, Lopes, Flavia Zon, Pretti, Percival Degrava, Sampaio-Barros, Fernando Henrique, Carlos de Souza, Eduardo Ferreira, Borba, Samuel Katsuyuki, Shinjo   +6 more
openaire   +2 more sources

[Treatment of systemic lupus erythematosus systemic].

La Revue du praticien, 1998
Patients with systemic lupus erythematosus require adequate information (sun avoidance, fair compliance, smoking discontinuation, adequate contraception and diet, pregnancy planning). Nonsteroidal antiinflammatory drugs and antimalarials are effective in patients presenting with skin and articular involvement.
openaire   +1 more source

Profiling autoreactive IgA antibodies against 124 autoantigens in Systemic lupus erythematosus, systemic scleroderma and idiopathic inflammatory myositis

The Journal of Immunology, 2016
Abstract Systemic lupus erythematosus (SLE), systemic scleroderma (SSc) and idiopathic inflammatory myositis (IIM) are systemic autoimmune diseases characterized by existing of circulating autoantibodies (AutoAbs) to a broad range of self-antigens.
Quanzhen Li, Hongjun Zhao, Mei Yan, Xiaoxia Zuo   +3 more
openaire   +1 more source

[Prevalence and clinical features of fibromyalgia in systemic lupus erythematosus, systemic sclerosis and Sjögren's syndrome].

Minerva medica, 2002
We studied the prevalence of fibromyalgia in 3 different groups of patients affected respectively with systemic lupus erythematosus, systemic sclerosis (scleroderma) and primary Sjögren's syndrome. The typical fibromyalgia findings encountered in these diseases were examined.We enrolled 250 consecutive outpatients: 100 with systemic lupus erythematosus,
OSTUNI, PIERANTONIO, BOTSIOS C, SFRISO, PAOLO, BERTAGNIN A, COZZI F, DORIA, ANDREA, TODESCO S.   +6 more
openaire   +2 more sources

Antibodies to ribonucleic acids detected by ELISA in systemic lupus erythematosus, systemic sclerosis and rheumatoid arthritis.

The Journal of rheumatology, 1986
The natural and synthetic antiribonucleic acid antibodies (anti-RNA) are more frequently found in systemic lupus erythematosus (SLE) (80%) than in systemic sclerosis (66%) or in rheumatoid arthritis (RA) (54.5%). SLE sera contain antibodies directed against a broader variety of RNA than systemic sclerosis sera and most RA sera. Fifty-two percent of SLE
O, Costa, K, Pinatel, J C, Monier
openaire   +1 more source

Anti-CD19 CAR T Cell Therapy for Refractory Systemic Lupus Erythematosus

Nature Medicine, 2022
Sebastian Boeltz, Arif Ekici, David Simon   +2 more
exaly